RUNX3 and neuroblastoma: Consistently, several patients categorized in the high-MYCN mRNA expression group who survived neuroblastoma concomitantly possessed high mRNA expressions of RUNX3, suggesting that RUNX3 has an ability to overcome the aggressive behavior of MYCN [80].